Quick and Easy, Preliminary and Emergency Medical Screening to Drive Rapid Diagnostic Testing Kits Market to USD 25.5 Billion by 2020

Rapid Diagnostic Testing (RDT) Kits Market – Global Medical Diagnostic Assays and Applications Analysis and Forecast 2013-2020, estimates the global skincare diagnostic and treatment devices market to reach nearly USD 25.5 Billion in 2020, at a CAGR of 5.0% from 2016 to 2020 - iHealthcareAnalyst, Inc.

Visit the Rapid Diagnostic Testing (RDT) Kits Market – Global Medical Diagnostic Assays and Applications Analysis and Forecast 2013-2020 report http://www.ihealthcareanalyst.com/report/rapid-medical-diagnostic-kits-market/

Rapid diagnostic tests (RDTs) are diagnostic assays designed for use at the point-of-care (POC), and can be adapted for use in low-resource settings. An RDT is low-cost, simple to operate and read, sensitive, specific, stable at high temperatures, and works in a short period of time. The rapid medical diagnostic testing kits market report estimates the market size (Revenue USD million - 2013 to 2020) for market segmentation based on diagnostic technologies or assays such as latex agglutination assays, flow-through assays, lateral flow immunoassays (immunochromatographic strip tests), solid-phase assays and their medical applications (clinical and or home based testing – blood glucose, infection, cholesterol, fertility and pregnancy, substance of abuse, and veterinary testing), and forecasts growth trends (CAGR% - 2016 to 2020). It also provides the detailed market landscape and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent acquisitions and alliances.

The global skincare diagnostic and treatment devices market is segmented as:

1. Diagnostic Assays
1.1. Flow-through Assays
1.2. Lateral Flow Immunoassays
1.3. Latex agglutination Assays
1.4. Solid-Phase Assays

2. Medical Application
2.1. Clinical Testing
2.1.1. Blood Glucose Testing
2.1.2. Cholesterol Monitoring
2.1.3. Fertility & Pregnancy Testing
2.1.4. Infectious Disease Testing
2.1.5. Substance Abuse Testing
2.2. Home Based
2.2.1. Blood Glucose Testing
2.2.2. Cholesterol Monitoring
2.2.3. Fertility & Pregnancy Testing
2.2.4. Infectious Disease Testing
2.2.5. Substance Abuse Testing<
2.3. Veterinary Testing

3. Geography (Region, Country)
3.1. North America (U.S., Canada)
3.2. Latin America (Brazil, Mexico, Rest of LA)
3.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
3.4. Asia Pacific (Japan, China, India, Rest of APAC)
3.5. Rest of the World

4. Company Profiles
4.1. Abaxis, Inc.
4.2. Abbott Laboratories, Inc.
4.3. Alere, Inc.
4.4. Becton, Dickinson & Company
4.5. Bio-Rad Laboratories, Inc.
4.6. Danaher Corporation (Beckman Coulter)
4.7. F. Hoffmann-La Roche Ltd.
4.8. MegaCor Diagnostik GmbH
4.9. Trinity Biotech plc.
4.10. Zoetis, Inc.

iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.

iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.

Ana Aitawa
iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Phone: (314) 736-9294.
Email: sales@ihealthcareanalyst.com
http://www.ihealthcareanalyst.com

This release was published on openPR.